Artificial Intelligence and Dysplasia Detection in Ulcerative Colitis (CUDISIA Study)
NCT ID: NCT05171634
Last Updated: 2024-06-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2021-05-05
2021-05-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Artificial Intelligence and Dysplasia Detection in Inflammatory Bowel Disease (EIIDISIA Study)
NCT06281392
A Study Using Artificial Intelligence to Identify Adults With Complex Perianal Fistulas Associated With Crohn's Disease
NCT04844593
Development and Validation of a Deep Learning Algorithm to Evaluate Endoscopic Disease Activity of Ulcerative Colitis.
NCT03973437
National Multicentric Observatory of Low Bowel Preparations in Patients With IBD
NCT03753425
Feasibility of a Multimodal Intervention Program to Optimize Treatment Outcomes in Ulcerative Colitis
NCT05743153
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
CROSSOVER
SCREENING
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Colonoscopy assisted by DiscoveryTM
DiscoveryTM
Colonoscopy assisted by an artificial intelligence system (DiscoveryTM).
Virtual Colonoscopy with iSCAN
iSCAN
Virtual colonoscopy assisted by iSCAN
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
DiscoveryTM
Colonoscopy assisted by an artificial intelligence system (DiscoveryTM).
iSCAN
Virtual colonoscopy assisted by iSCAN
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Involvement 30% of the colonic surface (or any extent if concomitant with PSC).
* Duration of the disease \>7 years (or any duration if concomitant with PSC).
Exclusion Criteria
* Previous colectomy (partial or complete).
* Coagulopathy that prevents biopsies or polypectomy.
* Colonoscopy performed in the previous 6 months.
* Pregnant or nursing women.
* Inadequate bowel preparation.
* Presence of endoscopic Ulcerative Colitis activity.
* Colonic stenosis and incomplete colonoscopy.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Valencia
OTHER
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Antonio López-Serrano
Chief of Endoscopy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Antonio López-Serrano
Valencia, , Spain
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Lopez-Serrano A, Voces A, Lorente JR, Santonja FJ, Algarra A, Latorre P, Del Pozo P, Paredes JM. Artificial intelligence for dysplasia detection during surveillance colonoscopy in patients with ulcerative colitis: A cross-sectional, non-inferiority, diagnostic test comparison study. Gastroenterol Hepatol. 2025 Feb;48(2):502210. doi: 10.1016/j.gastrohep.2024.502210. Epub 2024 May 11. English, Spanish.
Related Links
Access external resources that provide additional context or updates about the study.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CEIm: 62.21
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.